MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
notes payable
$250,000K
Proceeds from issuance of
common shares
$189,175K
Proceeds from maturities
of marketable...
$570,000K
Proceeds from issuance of
common shares under...
$1,833K
Net cash provided by
financing activities
$439,117K
Net cash provided by
(used in) investing...
$300,561K
Canceled cashflow
$1,891K
Canceled cashflow
$269,439K
Net increase
(decrease) in cash, cash...
$130,237K
Canceled cashflow
$609,441K
Payments of issuance
costs
$1,697K
Other financing
activities
-$194K
Non-cash share-based
compensation
$112,361K
Depreciation and
amortization
$9,922K
Change in fair value of
forward contract and...
-$9,426K
Issuance of common shares
as payment for...
$4,844K
Accrued expenses and
other current and...
$4,212K
Prepaid expenses,
income tax receivable,...
-$3,531K
Other non-cash items
-$174K
Purchases of marketable
securities
$266,875K
Other investing
activities
$1,849K
Purchases of property and
equipment
$715K
Net cash used in
operating activities
-$609,438K
Effect of exchange
rates on cash, cash...
-$3K
Canceled cashflow
$144,470K
Net loss
-$738,822K
Change in fair value of
notes payable
-$8,700K
Accounts payable
-$6,386K
Back
Back
Cash Flow
source: myfinsight.com
Biohaven Ltd. (BHVN)
Biohaven Ltd. (BHVN)